The Israel Innovation Authority announced a new series of International Technology Pilot Accelerator Programs. The initiative is designed to help Israeli technology companies expand into global markets through direct integration with leading innovation ecosystems worldwide.
The first cohort will include programs in the United States, Europe, and India. Participating companies will receive support valued at approximately NIS 300,000 per company.
In its initial phase, the authority will launch three pilot accelerator programs. One in the United States will focus on healthcare, one in Europe will focus on climate technologies, and one will operate in India. Approximately 10 Israeli companies are expected to participate in each program, with around 30 companies total in the first cohort.
The U.S. healthcare program, BreakthroughBio, will initially focus on the biotechnology and medical technology sectors. It will be operated by MassChallenge Boston, an accelerator in healthcare, life sciences, and technological innovation. Additional pilot accelerator programs in Europe and India are expected to launch in subsequent phases.
Selected startups will participate in intensive programs connecting them with R&D partners, multinational corporations, pilot sites, industry experts, investors, and regulatory authorities.
KEY QUOTE:
One of the greatest challenges facing Israeli startups is the transition from developing technology in Israel to conducting a first technological pilot with a leading global customer. This new program gives companies access to valuable resources, including industry connections, expertise, strategic partners and infrastructure within the world’s leading innovation hubs. By matching each company with the ecosystem best suited to its technology and business needs, we will help shorten development cycles, validate technologies under real market conditions and improve their chances of success.
Dror Bin, CEO of the Israel Innovation Authority
